Organogenesis is a regenerative medicine company based in Canton, Mass., focused on developing products for the wound care, surgical and sports medicine markets. By Shayna Korol - 5/23/18

Treating knee arthritis with NASHA (durolane hyaluronic acid) is a safe and effective procedure, according to a study in Open Access Rheumatology: Research and Reviews. By Shayna Korol - 5/22/18

Here are the 14 major players in the global spine biologics market, according to an E Market Research report. By Shayna Korol - 5/21/18

Mikkel O. Andersen, MD, of Middelfart Hospital in Denmark, reported results from the IVANOS study investigating Cerapedics' i-FACTOR Peptide Enhanced Bone Graft. By Megan Wood - 5/21/18

Burst Biologics, based in Boise, Idaho, is a regenerative medicine company. By Shayna Korol - 5/18/18

Orthopedic surgeons continue to express concerns over various stem cell treatments being offered to patients, according to Contact7. By Mackenzie Garrity - 5/17/18

Insurers will not usually pay for unproven stem cell treatments, so patients seeking those interventions must pay out-of-pocket or use social media to receive donations, a practice known as crowdfunding. Medical crowdfunding campaigns may convey misleading messages about stem cell-based interventions, according to a JAMA study. By Shayna Korol - 5/16/18

NuVasive's biologics portfolio includes AttraX Putty. By Shayna Korol - 5/15/18

Osteoarthritis-mesenchymal stem cells may drive cartilage degeneration pathogenesis and should be targeted in osteoarthritis therapy, according to a study in Scientific Reports. By Shayna Korol - 5/14/18

Researchers successfully grafted induced pluripotent stem cell-derived neural precursor cells into the spinal cords of pigs with and without spinal cord injury with only temporary immunosuppression, according to a study in Science Translational Medicine. By Shayna Korol - 5/11/18

The U.S. Department of Justice filed lawsuits to shut down stem cell clinics in Florida and California that marketed unapproved stem cell treatments, the Los Angeles Times reports. By Shayna Korol - 5/10/18

Transplanted human spinal cord-derived neural stem cells may stabilize functioning in amyotrophic lateral sclerosis patients, according to a study in the Annals of Clinical and Translational Neurology. By Shayna Korol - 5/9/18

The New York City Stem Cell Institute named Alexandre Scheer, MD, medical director. By Megan Wood - 5/9/18

The global spine biologics market will likely grow at a compound annual growth rate of 4.5 percent between 2018 and 2023, based on a Market.biz report, according to Business News. By Megan Wood - 5/8/18

Bone Biologics, based in Burlington, Mass., is a publicly traded company focused on orthobiologic solutions. By Shayna Korol - 5/7/18

Luga Podesta, MD, is a sports medicine and regenerative orthopedic specialist at Bluetail Medical Group in Naples, Fla. He was the lead author in a 2013 study in The American Journal of Sports Medicine which demonstrated that platelet-rich plasma can effectively treat partial UCL tears in athletes. In a recent interview with Becker's Spine Review, Dr. Podesta spoke about the possibilities and pitfalls of stem cell therapies in orthopedics and trends in regenerative medicine. By Shayna Korol - 5/4/18

The global orthobiologics market is expected to grow from $4.66 billion in 2017 to reach $8.06 billion by 2023, increasing at a 5.7 percent compound annual growth rate, according to a Market.Biz report. By Shayna Korol - 5/3/18

U.K.-based Tissue Regenix Group inked a deal with Premier for TRX's flagship product DermaPure to maintain access to 3,900 hospitals and more than 150,000 healthcare providers in the U.S., according to proactiveinvestors UK. By Shayna Korol - 5/2/18

Biologica Technologies will exhibit clinical data for its ProteiOS growth factor at the American Association of Neurological Surgeons Annual Scientific Meeting in New Orleans. By Shayna Korol - 5/2/18

Infuse gets new FDA indication for lateral, anterior spinal fusions with PEEK implants: 5 things to know By Laura Dyrda - 4/30/18